Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
107.50
-0.50 (-0.46%)
Apr 20, 2026, 1:24 PM CST

TPE:6919 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
38.0438.0444.4338.9312.8212.34
Revenue Growth (YoY)
-6.00%-14.40%14.13%203.68%3.90%19.22%
Cost of Revenue
11.5211.5213.6711.463.213.11
Gross Profit
26.5226.5230.7627.479.619.23
Selling, General & Admin
90.2183.2197.7936.9534.2159.35
Research & Development
661.89650.54650.12503.99295.02180.62
Operating Expenses
752.1733.74747.91540.94329.23239.97
Operating Income
-725.57-707.22-717.14-513.47-319.62-230.73
Interest Expense
-0.11-0.16-0.33-0.5-0.67-2.9
Interest & Investment Income
268.08233.0774.2117.425.190.1
Currency Exchange Gain (Loss)
173.8122.738.63-1.0314.23-1.07
Other Non Operating Income (Expenses)
-0.3-0.3115.819.1214.8310.34
EBT Excluding Unusual Items
-284.11-351.92-588.83-488.46-286.05-224.26
Gain (Loss) on Sale of Assets
-----0.11-
Pretax Income
-284.11-351.92-588.83-488.46-286.16-224.26
Income Tax Expense
-----0.03
Net Income
-284.11-351.92-588.83-488.46-286.16-224.29
Net Income to Common
-284.11-351.92-588.83-488.46-286.16-224.29
Shares Outstanding (Basic)
1,5461,5431,4301,2391,171920
Shares Outstanding (Diluted)
1,5461,5431,4301,2391,171920
Shares Change (YoY)
5.54%7.94%15.40%5.77%27.35%23.49%
EPS (Basic)
-0.18-0.23-0.41-0.39-0.24-0.24
EPS (Diluted)
-0.18-0.23-0.41-0.39-0.24-0.24
Free Cash Flow
-348.01-442.43-532.31-432.54-256.93-125.6
Free Cash Flow Per Share
-0.23-0.29-0.37-0.35-0.22-0.14
Gross Margin
69.72%69.72%69.23%70.56%74.94%74.83%
Operating Margin
-1907.45%-1859.31%-1613.95%-1318.88%-2493.17%-1869.95%
Profit Margin
-746.88%-925.20%-1325.18%-1254.64%-2232.10%-1817.76%
Free Cash Flow Margin
-914.89%-1163.16%-1197.97%-1111.01%-2004.12%-1017.90%
EBITDA
-702.48-684.64-695.71-493.68-302.36-214.49
D&A For EBITDA
23.0922.5821.4319.7917.2616.24
EBIT
-725.57-707.22-717.14-513.47-319.62-230.73
Advertising Expenses
---0.06--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.